Immunofluorescence detection of clinicopathological specimens also found that the immune infiltration level of M2-TAMs in breast cancer tissues with high COL11A1 expression was significantly higher than that in breast cancer tissues with low COL1A1 expression (Figure 6C). This evidence concerns the gene COL11A1 and breast cancer.